JPWO2022046809A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022046809A5
JPWO2022046809A5 JP2023513299A JP2023513299A JPWO2022046809A5 JP WO2022046809 A5 JPWO2022046809 A5 JP WO2022046809A5 JP 2023513299 A JP2023513299 A JP 2023513299A JP 2023513299 A JP2023513299 A JP 2023513299A JP WO2022046809 A5 JPWO2022046809 A5 JP WO2022046809A5
Authority
JP
Japan
Prior art keywords
seq
sequence
feline
fusion protein
raav vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023513299A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539247A5 (https=
JP2023539247A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/047403 external-priority patent/WO2022046809A1/en
Publication of JP2023539247A publication Critical patent/JP2023539247A/ja
Publication of JPWO2022046809A5 publication Critical patent/JPWO2022046809A5/ja
Publication of JP2023539247A5 publication Critical patent/JP2023539247A5/ja
Pending legal-status Critical Current

Links

JP2023513299A 2020-08-24 2021-08-24 Glp-1受容体アゴニスト融合物をコードするウイルスベクター及びネコの代謝性疾患の治療におけるその使用 Pending JP2023539247A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063069492P 2020-08-24 2020-08-24
US63/069,492 2020-08-24
PCT/US2021/047403 WO2022046809A1 (en) 2020-08-24 2021-08-24 Viral vector encoding glp-1 receptor agonist fusions and uses thereof in treating metabolic diseases in felines

Publications (3)

Publication Number Publication Date
JP2023539247A JP2023539247A (ja) 2023-09-13
JPWO2022046809A5 true JPWO2022046809A5 (https=) 2024-09-02
JP2023539247A5 JP2023539247A5 (https=) 2024-09-02

Family

ID=80355670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023513299A Pending JP2023539247A (ja) 2020-08-24 2021-08-24 Glp-1受容体アゴニスト融合物をコードするウイルスベクター及びネコの代謝性疾患の治療におけるその使用

Country Status (8)

Country Link
US (1) US20230405150A1 (https=)
EP (1) EP4199942A4 (https=)
JP (1) JP2023539247A (https=)
KR (1) KR20230054419A (https=)
CN (1) CN116390745A (https=)
AU (1) AU2021332232A1 (https=)
CA (1) CA3190396A1 (https=)
WO (1) WO2022046809A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026039359A1 (en) 2024-08-12 2026-02-19 Akston Biosciences Corporation Fc fusion protein therapeutics for companion animal obesity and methods of use
WO2026039340A1 (en) 2024-08-12 2026-02-19 Akston Biosciences Corporation Fc fusion protein therapeutics for companion animal obesity and methods of use
WO2026039341A1 (en) 2024-08-12 2026-02-19 Akston Biosciences Corporation Fc fusion protein therapeutics for companion animal obesity and methods of use
CN120005002B (zh) * 2025-04-22 2025-07-25 西宝生物科技(上海)股份有限公司 一种glp-1类似物的生物发酵制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0116024A (pt) * 2000-12-07 2005-12-13 Lilly Co Eli Proteìna de fusão heteróloga e uso da mesma
CA2833623A1 (en) * 2011-04-20 2012-10-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
EP3332012A4 (en) * 2015-08-06 2019-01-16 The Trustees of The University of Pennsylvania GLP-1 AND USE THEREOF IN COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES
CN110267674A (zh) * 2016-07-08 2019-09-20 奥美药业有限公司 包含瘦素的融合蛋白及其生产和使用方法
BR112020002871A2 (pt) * 2017-08-15 2020-07-28 Kindred Biosciences, Inc. variantes fc de igg para uso veterinário
MX2021007680A (es) * 2018-12-27 2021-10-13 Kindred Biosciences Inc Variantes de igg fc para uso veterinario.

Similar Documents

Publication Publication Date Title
JP7654562B2 (ja) 線維芽細胞増殖因子23関連低リン血症性疾患の遺伝子療法
JP2020510428A5 (https=)
CN111954537A (zh) 生长分化因子15融合蛋白
WO2006102072A2 (en) Use of a pa131 polypeptide in treatment of atherosclerosis
JP2023539247A (ja) Glp-1受容体アゴニスト融合物をコードするウイルスベクター及びネコの代謝性疾患の治療におけるその使用
JP7840319B2 (ja) Glp-1受容体アゴニスト融合物をコードするウイルスベクター及び代謝性疾患の治療におけるその使用
JPWO2021102107A5 (https=)
JPWO2022046809A5 (https=)
US20250171515A1 (en) Aav vectors for delivery of glp-1 receptor agonist fusions
JP2021521782A5 (https=)
WO2023045996A1 (zh) 一种用于糖代谢相关疾病基因治疗的核酸构建体
JPWO2020167996A5 (https=)
JPWO2020047467A5 (https=)
CN119522285A (zh) 编码glp-2受体激动剂融合物的病毒载体及其在治疗短肠综合征中的用途
JPWO2020237130A5 (https=)
JPWO2022015418A5 (https=)
JPWO2019204303A5 (https=)
WO2026035486A2 (en) G protein-coupled receptor (gpcr) agonists and use thereof
HK40091844A (zh) 双功能蛋白质和包含其的药物组合物
HK40086042A (zh) 双功能蛋白质和包含其的药物组合物
JPWO2022165421A5 (https=)
CA3215384A1 (en) Methods and means for the prevention and/or treatment of hemophilic arthropathy in hemophilia
JPWO2023168411A5 (https=)
JPWO2022006551A5 (https=)
RU2021123108A (ru) Генотерапевтические конструкции для лечения болезни вильсона